We are live on ! Find out more
LP

Longview Partners Portfolio holdings

AUM $6.16B
1-Year Est. Return 3.55%
This Fund
S&P 500
This Quarter Est. Return
+16.74%
1 Year Est. Return
+3.55%
3 Year Est. Return
+35.76%
5 Year Est. Return
+55.83%
10 Year Est. Return
+255.17%
AUM
$21.1B
AUM Growth
+$2.5B
Cap. Flow
-$286M
Cap. Flow %
-1.36%
Top 10 Hldgs %
50.57%
Holding
27
New
2
Increased
3
Reduced
21
Closed
1

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$924M
2
SYY icon
Sysco
SYY
+$234M
3
ZBH icon
Zimmer Biomet
ZBH
+$216M
4
MDT icon
Medtronic
MDT
+$95.9M
5
IQV icon
IQVIA
IQV
+$53.5M

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$887M
2
PH icon
Parker-Hannifin
PH
+$264M
3
STT icon
State Street
STT
+$125M
4
GWW icon
W.W. Grainger
GWW
+$77M
5
ORCL icon
Oracle
ORCL
+$76.9M

Sector Composition

Rank Sector Weight
1 Financials 27.42%
2 Healthcare 23.33%
3 Technology 15.16%
4 Industrials 15.02%
5 Communication Services 11.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FTDR icon
26
Frontdoor
FTDR
$5.52B
$148M 0.7%
3,336,157
-69,122
-2% -$2.82M
AGN
27
DELISTED
Allergan plc
AGN
-5,010,929
Closed -$887M

Similar funds

Longview Partners's Q2 2020 Portfolio in Review

As of Q2 2020, Longview Partners held 27 positions worth $21.1B, up 13% from $18.6B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Longview Partners's Q2 2020 filing shows 2 new, 3 increased, 21 reduced and 1 closed positions. Its largest new stake was Alphabet (Google) Class A: 13,707,380 shares worth $972M. The largest sale was Allergan plc, an estimated $887M.

By sector, the portfolio is most concentrated in Financials at 27% of assets, down from 29% a quarter earlier, followed by Healthcare and Technology.

  • Longview Partners's largest Q2 2020 buy was Alphabet (Google) Class A: 13,707,380 shares worth $972M.
  • Longview Partners added most to Sysco in Q2 2020, an estimated $234M increase.
  • Longview Partners's biggest Q2 2020 reduction was Parker-Hannifin, cutting an estimated $264M.
  • Longview Partners fully exited Allergan plc in Q2 2020, selling an estimated $887M.
  • Longview Partners's ten largest holdings make up 51% of its $21.1B portfolio in Q2 2020.
  • Longview Partners opened 2 new positions and closed 1 in Q2 2020.
  • Longview Partners's portfolio value rose 13% quarter-over-quarter to $21.1B.

Based on Longview Partners's 13F filing for Q2 2020, filed 14 Aug 2020.